Abstract
Aims: Oncotype Dx is a multi-gene test used to help define the prognosis in ER+ve node -ve breast cancer. This audit examines whether there is any further patient or pathological data that might refine the population that should get the oncotype funded.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have